Buscar
Congreso SOLACI
HomeInternational CongresseseuroPCR 2014.

euroPCR 2014.

Ver Categoría
Day 3

NOBORI II: Final 5-year results of drug-eluting stent with bio-absorbable polymer

This study evaluated the performance of Nobori biolimus bio-absorbable polymer stent in real-world patients. A total of...
solaci -
Ver más
Day 3

SOURCE XT: Results at 2 years of SAPIEN XT valve

Multicenter prospective study included 2688 patients with a mean age of 81.4 years and 20.5 EuroScore. The...
solaci -
Ver más
Day 3

DISCOVER Trial: Results at one year of the new nonmetallic percutaneous aortic valve

Direct Flow Medical prosthesis is a nonmetallic, repositionable, recaptured valve (even after posts dilate), that does not...
solaci -
Ver más
Day 3

REDUCE-HTN: safety and efficacy of new bipolar device for renal denervation

This study included 146 patients with resistant hypertension who were medicated with an average of 5.4 drugs....
solaci -
Ver más
Day 3

POST -IT: The FFR modifies strategy in almost half of patients

The use of FFR to guide treatment showed improved outcomes in previous studies. However, there are few...
solaci -
Ver más
Day 3

UK TAVI Registry: Long-term results of TAVI in the UK

This record has been created in order to evaluate the results of percutaneous aortic valve replacement in...
solaci -
Ver más
Day 3

TRYTON dedicated bifurcation stent in left main coronary artery

TRYTON is a cobalt chromium device specifically dedicated for bifurcation lesions to be implanted in the side...
solaci -
Ver más
Day 3

Safety and efficacy of a new multi-electrode device for simultaneous renal ablation

This study aimed to establish the safety and effectiveness of renal denervation using the new multielectrode device...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad